Alpine Global Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Alpine Global Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,150	Closed	-$606K	–	277
2023 Q1	$606K	Buy	+25,150	New	+$316K	0.24%	50
2022 Q1	–	Sell	-16,074	Closed	-$90K	–	801
2021 Q4	$90K	Buy	+16,074	New	+$102K	0.01%	680
2020 Q1	–	Sell	-14,535	Closed	-$217K	–	486
2019 Q4	$217K	Buy	+14,535	New	+$130K	0.05%	312

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Alpine Global Management's PRVB Position: Q2 2023 in Review

Alpine Global Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 25,150 shares — an estimated $606K sold.

Alpine Global Management first reported a position in PRVB in Q4 2019 and held it in 3 quarters. The position peaked at $606K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Alpine Global Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Alpine Global Management sold 25,150 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $606K.
Alpine Global Management first reported a position in Provention Bio, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
Alpine Global Management's Provention Bio, Inc. Common Stock position peaked at $606K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Alpine Global Management's 13F filing for Q2 2023, filed 14 Aug 2023.